Pump Fuel Insanity Psycho Strawberry
Withdrawn from the US market on 2 April 2024 (according to the DSLD)
PMD Platinum, food supplement from the US market
Label withdrawn from the US market. Pump Fuel Insanity Psycho Strawberry (PMD Platinum), a food supplement au code-barres 811020901600, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 50 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Potassium: up to 90 mg a day according to the label (at most 1 serving a day), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- PMD Platinum
- Barcode
- 811020901600
- Form
- Powder
- One serving
- 28 g
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Citric Acid, Malic Acid, Silica, Natural and Artificial flavors, Sucralose, Acesulfame Potassium, FD&C Red 40 powder Alum Lake, FD&C Red 40
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 55 kcal |
| Calories from Fat | Other | 0 kcal |
| Total Fat | Fat | 0 Gram(s) |
| Saturated Fat | Fat | 0 Gram(s) |
| Trans Fat | Fat | 0 Gram(s) |
| L-Arginine | Amino acid | not stated |
| L-Arginine AKG | Other substance | not stated |
| Di-Arginine Di-Malate | Amino acid | not stated |
| Agmatine Sulphate | Other substance | not stated |
| L-Norvaline | Amino acid | not stated |
| L-Citrulline L-Malate | Other substance | not stated |
| Cholesterol | Fat | 0 mg |
| Total Carbohydrates | Carbohydrate | 14 Gram(s) |
| Dietary Fiber | Fibre | 0 Gram(s) |
| Sugar | Carbohydrate | 0 Gram(s) |
| Protein | Protein | 0 Gram(s) |
| Vitamin C | Vitamin | 125 mg |
| Vitamin E | Vitamin | 100 UI |
| Calcium | Mineral | 80 mg |
| Creatine | Other substance | 2,000 mg |
| Magnesium Creatine Chelate | Other substance | 1,000 mg |
| Arginine Complex | Blend | 2,000 mg |
| Agmatine Complex | Blend | 250 mg |
| CarnoSyn | Amino acid | 2,500 mg |
| Taurine | Other substance | not stated |
| Caffeine Anhydrous | Other substance | 275 mg |
| Amla (Phyllanthus emblica) (fruit) extract (Phyllanthus emblica) | Plant | not stated |
| Bitter Orange (Citrus aurantium) (fruit) extract (Citrus aurantium) | Plant | not stated |
| Carnitine Tartrate | Other substance | not stated |
| Glutamine | Amino acid | not stated |
| Glutamine AKG | Other substance | not stated |
| Guanidino Propionic Acid | Other substance | not stated |
| Isoleucine | Amino acid | not stated |
| Leucine | Amino acid | not stated |
| N-Acetyl Glutamine | Other substance | not stated |
| Phosphatidyl Serine | Fat | not stated |
| Valine | Amino acid | not stated |
| Cinnamon bark extract (Cinnamomum verum) | Plant | not stated |
| Tyrosine | Amino acid | not stated |
| Vinpocetine | Other substance | not stated |
| Maltodextrin | Carbohydrate | not stated |
| Waxy Maize | Carbohydrate | not stated |
| Glycerol powder | Other | not stated |
| Glycine Propionyl L-Carnitine HCl | Other substance | not stated |
| Acetyl L-Carnitine Arginate DiHCl | Other substance | not stated |
| Phosphorous | Mineral | 40 mg |
| Magnesium | Mineral | 100 mg |
| Chromium | Mineral | 50 µg |
| Sodium | Mineral | 40 mg |
| Potassium | Mineral | 90 mg |
| PUMP FUEL(R) INSANITY Blend | Blend | 23,362 mg |
| RAPID ATP(TM) v.3 Blend | Blend | 3,000 mg |
| AGMA PUMP(TM) Blend | Blend | 2,250 mg |
| Beta Burn Agent | Blend | 2,500 mg |
| AMINO FOCUS Blend | Blend | 1,114 mg |
| GLYCOL LOAD(TM) Blend | Blend | 14,498 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Amla (Phyllanthus emblica) (fruit) extract
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Cinnamon bark extract
Read the warning, when it applies and the studies cited
Cinnamon - Cinnamomum Verum
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
- OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé.
Condition of application: All products except antioxidants.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
- BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs—Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Tyrosine
Read the warning, when it applies and the studies cited
L-TYROSINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : PMD Platinum
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Pump Fuel Insanity Psycho Strawberry : étiquette retirée du marché américain (PMD Platinum): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/811020901600-pump-fuel-insanity-psycho-strawberry-pmd-platinum, updated 2 April 2024.